secwatch.observer — SEC 8-K summary
======================================

Issuer:     EVOME MEDICAL TECHNOLOGIES INC. (—)
CIK:        0001617765
Form:       8-K
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001062993-23-015393
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salona Global appoints Michael Seckler permanent CEO; cuts $2M annual costs, reduces debt by 15%
--------------------------------------------------------------------------------

- Michael Seckler appointed permanent CEO effective July 24, 2023; was interim CEO since June 13.
- Annual salary $100k plus up to $200k variable; options for 750k shares at C$0.29 vesting over 3 years.
- Debt reduced 15% from ~$10M to ~$8.5M via inventory debt offset; late-stage restructuring discussions ongoing.
- Annualized cost cuts of over $2M implemented; management targets profitability in quarter ending Sep 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617765/000106299323015393/0001062993-23-015393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617765/000106299323015393/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-23-015393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer